EP2018173A4 - Magnetorheological fluids and therapeutic uses thereof - Google Patents

Magnetorheological fluids and therapeutic uses thereof

Info

Publication number
EP2018173A4
EP2018173A4 EP07783892A EP07783892A EP2018173A4 EP 2018173 A4 EP2018173 A4 EP 2018173A4 EP 07783892 A EP07783892 A EP 07783892A EP 07783892 A EP07783892 A EP 07783892A EP 2018173 A4 EP2018173 A4 EP 2018173A4
Authority
EP
European Patent Office
Prior art keywords
therapeutic uses
magnetorheological fluids
magnetorheological
fluids
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07783892A
Other languages
German (de)
French (fr)
Other versions
EP2018173A1 (en
Inventor
William J Murphy
Lisbeth A Welniak
Cahit Evrensel
Alan Fuchs
Fararmarz Gordaninejad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEVADA, University of
Nevada System of Higher Education NSHE
Original Assignee
NEVADA, University of
Nevada System of Higher Education NSHE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEVADA, University of, Nevada System of Higher Education NSHE filed Critical NEVADA, University of
Publication of EP2018173A1 publication Critical patent/EP2018173A1/en
Publication of EP2018173A4 publication Critical patent/EP2018173A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2013IL-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
EP07783892A 2006-05-17 2007-05-17 Magnetorheological fluids and therapeutic uses thereof Withdrawn EP2018173A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80146306P 2006-05-17 2006-05-17
PCT/US2007/069170 WO2007137130A1 (en) 2006-05-17 2007-05-17 Magnetorheological fluids and therapeutic uses thereof

Publications (2)

Publication Number Publication Date
EP2018173A1 EP2018173A1 (en) 2009-01-28
EP2018173A4 true EP2018173A4 (en) 2009-09-23

Family

ID=38723628

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07783892A Withdrawn EP2018173A4 (en) 2006-05-17 2007-05-17 Magnetorheological fluids and therapeutic uses thereof

Country Status (5)

Country Link
US (1) US20100063346A1 (en)
EP (1) EP2018173A4 (en)
JP (1) JP2009537567A (en)
CA (1) CA2651763A1 (en)
WO (1) WO2007137130A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103898087A (en) * 2012-11-29 2014-07-02 微观生物科技公司 Shielding of magnetic field as a medical therapy
KR20240024448A (en) * 2022-08-17 2024-02-26 서울대학교산학협력단 Superparamagnetic Iron Oxide Nanoparticles[SPIONs] for immunotherapy
KR20240024457A (en) * 2022-08-17 2024-02-26 서울대학교산학협력단 Method for producing Superparamagnetic Iron Oxide Nanoparticles[SPIONs] for immunotherapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438971A1 (en) * 2001-10-25 2004-07-21 TTC CO., Ltd. Immunopotentiators in thermotherapy for cancer
WO2006108405A2 (en) * 2005-04-12 2006-10-19 Magforce Nanotechnologies Ag Nanoparticle/active ingredient conjugate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5067952A (en) * 1990-04-02 1991-11-26 Gudov Vasily F Method and apparatus for treating malignant tumors by local hyperpyrexia
US5236410A (en) * 1990-08-02 1993-08-17 Ferrotherm International, Inc. Tumor treatment method
US6296604B1 (en) * 1999-03-17 2001-10-02 Stereotaxis, Inc. Methods of and compositions for treating vascular defects
US6532387B1 (en) * 1999-03-26 2003-03-11 Kevin S. Marchitto Catheter for delivering electromagnetic energy for enhanced permeation of substances
EP1482956A1 (en) * 2002-02-01 2004-12-08 Vanderbilt University Targeted drug delivery methods
US7282479B2 (en) * 2003-03-31 2007-10-16 Ttc Co., Ltd. Hyperthermia agent for malignant tumor comprising cytokine and magnetic fine particles
KR100579153B1 (en) * 2003-07-11 2006-05-12 김종오 Radioactive magnetic fluids for treatment or diagnosis of cancer, process for preparaing them and use thereof
US7448389B1 (en) * 2003-10-10 2008-11-11 Materials Modification, Inc. Method and kit for inducing hypoxia in tumors through the use of a magnetic fluid
US20060142631A1 (en) * 2004-12-29 2006-06-29 Attila Meretei Systems and methods for occluding a blood vessel

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438971A1 (en) * 2001-10-25 2004-07-21 TTC CO., Ltd. Immunopotentiators in thermotherapy for cancer
WO2006108405A2 (en) * 2005-04-12 2006-10-19 Magforce Nanotechnologies Ag Nanoparticle/active ingredient conjugate

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2007137130A1 *
SHINKAI M ET AL: "Intracellular hyperthermia for cancer using magnetite cationic liposomes", JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 194, no. 1-3, 1 April 1999 (1999-04-01), pages 176 - 184, XP004166664, ISSN: 0304-8853 *

Also Published As

Publication number Publication date
CA2651763A1 (en) 2007-11-29
JP2009537567A (en) 2009-10-29
EP2018173A1 (en) 2009-01-28
WO2007137130A1 (en) 2007-11-29
US20100063346A1 (en) 2010-03-11

Similar Documents

Publication Publication Date Title
GB2467670B (en) Chemical entities and therapeutic uses thereof
GB0625659D0 (en) Therapeutic compounds and their use
HK1183253A1 (en) Catheter assembly and components thereof
ZA200810323B (en) Fkbp-l and uses thereof
ZA201003036B (en) Bupropion hydrobromide and therapeutic applications
IL194751A0 (en) Drugs and uses
PL2064327T3 (en) Dbait and uses thereof
HK1208000A1 (en) Thioninium compounds and their use
HK1136819A1 (en) Novel dithiolopyrrolones and their therapeutic applications
HK1133552A1 (en) Carboranylporphyrins and uses thereof
HK1142811A1 (en) Bupropion hydrobromide and therapeutic applications
GB0611115D0 (en) Compounds and their use
EP2111226A4 (en) Cyclitols and their derivatives and their therapeutic applications
PL2012805T3 (en) Therapeutic composition and use
EP2195316A4 (en) Activators and therapeutic applications thereof
EP2069371A4 (en) Organo-arsenoxide compounds and use thereof
EP2097085A4 (en) Therapeutic materials and methods
EP2018173A4 (en) Magnetorheological fluids and therapeutic uses thereof
EP2231163A4 (en) Compounds and therapeutic use thereof
GB0701728D0 (en) Assays and therapy
GB0619611D0 (en) Compounds and their use
GB0614538D0 (en) Therapeutic Compounds And Their Use
GB0608806D0 (en) Combination therapy product and uses thereof
GB0602744D0 (en) Amine and its therapeutic use
GB0625633D0 (en) Therapeutic compounds and their use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081117

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: GORDANINEJAD, FARARMARZ

Inventor name: FUCHS, ALAN

Inventor name: EVRENSEL, CAHIT

Inventor name: WELNIAK, LISBETH, A.

Inventor name: MURPHY, WILLIAM, J.

A4 Supplementary search report drawn up and despatched

Effective date: 20090825

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 41/00 20060101ALI20090819BHEP

Ipc: A61P 35/00 20060101ALI20090819BHEP

Ipc: A61K 51/00 20060101ALI20090819BHEP

Ipc: A61K 33/26 20060101AFI20080218BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20091111